Kempinski Hotels Extends Strategic Partnership with BTG Hotels to Grow Luxury Hospitality Offering in China
GENEVA, April 16, 2025 /PRNewswire/ -- Building on over 30 years of…
Golden Minerals Reports Full Year 2024 Results
GOLDEN, Colo.--(BUSINESS WIRE)--$AUMN #gold--Golden Minerals Company (“Golden Minerals,” “Golden” or the “Company”)…
Delek US Holdings to Host First Quarter 2025 Conference Call on May 7th
BRENTWOOD, Tenn.--(BUSINESS WIRE)--Delek US Holdings, Inc. (NYSE: DK) (“Delek US”) today announced…
Improving’s Acquisition of InfraCloud Boosts Development Capabilities in Asia
DALLAS, April 15, 2025 /PRNewswire/ -- Improving, a modern digital services organization, has acquired…
RTI Earns 2025 Great Place To Work Certification in the U.S. and Spain for the Seventh Consecutive Year
SUNNYVALE, Calif., April 15, 2025 (GLOBE NEWSWIRE) -- Real-Time Innovations (RTI), the…
Shilton Hospitality’s 22 Catering Reaches Milestone of 500 Events serving 1 million people in 3 Years
BENGALURU, India, April 15, 2025 /PRNewswire/ -- Shilton Hospitality, a leading hospitality…
The Internet Is in a Frenzy Over MelBet India’s New Ad Campaign With Sherlyn Chopra
MUMBAI, India, April 15, 2025 /PRNewswire/ -- After a week of teaser-fueled anticipation,…
Marimekko and Blue Bottle Coffee Celebrate Finnish Coffee Culture and the Joy of Everyday Rituals
Limited-edition collaboration launches in North America and Asia on April 25 OAKLAND,…
Scilex Holding Company Announces Approval of a New Drug Submission (NDS) from the Health Canadas Pharmaceutical Drugs Directorate, Bureau of Cardiology, Allergy and Neurological Sciences for ELYXYBs Acute Treatment of Migraine With or Without Aura in Cana
April 15, 2025 09:00 ET | Source: Scilex Holding Company ELYXYB® is…
NeurAxis to Present at the Planet MicroCap Showcase: VEGAS in partnership with MicroCapClub on Wednesday, April 23, 2025 & 1×1 Meetings on Thursday, April 24, 2025
CARMEL, Ind., April 15, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or…